50mg ghk-cu Buy & 100mg - Copper Tripeptide GHK-Cu 50mg Lyophilised Solid Research

Clinical trials are needed to confirm safety and dosing

In late 2023, the FDA added more than a dozen peptides including both BPC-157 and thymosin alpha 1 to its list of substances that should not be compounded because the agency has identified potential significant safety risks. For BPC-157, the agency warned that the peptide could trigger an immune response

At picomolar to nanomolar concentrations, it enhances extracellular matrix (ECM) remodeling and granulation tissue formation for wound healing

Customer service was responsive and helpful whenever I reached out

[DOI] [PMC free article] [PubMed] [Google Scholar] 252.Venereau E., Casalgrandi M., Schiraldi M., Antoine D.J., Cattaneo A., De Marchis F., Liu J., Antonelli A., Preti A., Raeli L